Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye Diseases
https://doi.org/10.18008/1816-5095-2021-3-566-577
Abstract
The problem of diagnosis and treatment of inflammatory eye diseases takes a leading place in Russia and in the world, but the most important thing is the correct choice of treatment methods. Purpose of the work: collection and analysis of data on doctors’ preferences under prescribing therapy in patients with inflammatory eye pathology in routine clinical practice. As a result, 5960 clinical cases from 47 Russian cities were analyzed. This article compiles data from October to November 2020. 151 medical researchers were taken part in the participation of the recruitment. Doctors made different diagnoses for referring patients, but significantly more often diagnosis H10.3 was detected — 17.99 % (in 1072 patients). Ophthalmologists preferred to prescribe the following combination of drugs: 1 — antibacterial local, 2 — local antiseptics, 3 — non-steroidal anti-inflammatory local, a combination (antibiotic and glucocorticosteroid), antiallergic in the form of drops of local action. The choice of drugs for inflammatory eye disease is determined by their high efficiency of use for a given disease: antibiotic Signicef® (levofloxacin 0,5 %), nonsteroidal anti-inflammatory drug Broxinac® (bromphenac 0,09 %), fixed combination Kombinil® (ciprofloxacin 0,3 % + dexamethasone 0,1 %), Visallergol® (olopatadine 0,2 %) in the form of topical eye drops.
About the Authors
I. V. Vorobyeva
Russian Medical Academy of Continuous Professional Education;
Peoples’ Friendship University of Russia (RUDN University)
Russian Federation
Russian Federation
Vorobyeva Irina V., МD, Associate Professor of the Ophthalmology Department
Barrikadnaya str., 2/1, bld.1, Moscow, 123242;
Miklukho-Maklaya str., 6, Moscow, 117198
M. A. Frolov
Peoples’ Friendship University of Russia (RUDN University)
Russian Federation
Russian Federation
Frolov Michael A., MD, Professor, head of the Eye Diseases Department
Miklukho-Maklaya str., 6, Moscow, 117198
Yu. B. Slonimskiy
Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Slonimskiy Yuriy B., MD, Professor
Barrikadnaya str., 2/1, bld.1, Moscow, 123242
References
1. Neroev V.V., Vakhova E.S. Diseases of the conjunctiva. In book: Ophthalmology. National leadership. Eds by Avetisov S.E., Egorov E.A., Moshetova L.K., Neroev V.V., Takhchidi H.P. Moscow, 2018 (In Russ.).
2. Chernakova G.M., Maychuk D.Yu., Murtazalieva S.M., Slonimsky Yu.B., Klescheva E.A., Yatsyshina S.B., Ageeva M.R. Epidemiological, etiological and clinical aspects of acute infectious conjunctivitis — at the crossroads of ophthalmology and epidemiology (clinical and laboratory research). Оphthalmology in Russia = Oftal’mologiya. 2018;(4):476–483 (In Russ.). DOI: 10.18008/1816-5095-2018-4-476-483
3. Arestova N.N., Katargina L.A., Yani E.V. Conjunctivitis and dacryocystitis in children: clinical characteristics, modern treatment options. Russian Pediatric Ophthalmology = Rossiyskaya pediatricheskaya oftal’mologiya. 2016;(4):200–206 )In Russ.)] DOI: 10.18821/1993-1859-2016-11-4-200-206
4. Maychuk Yu.F. Acute conjunctivitis. Consilium provisorum. 2004;2:22–24 (In Russ.).
5. Akopova E.B., Maychuk D.Yu., Loshkareva A.O., Simonova T.A. Analysis of the nature and resistance of bacterial microflora in patients with conjunctivitis and keratoconjunctivitis. Modern technologies in ophthalmology = Sovremennye tekhnologii v oftal’mologii. 2018;4:6–18 (In Russ.).
6. Chernakova G.M., Maychuk D.Yu., Malysheva Z.G. Results of enzyme immunoassay of blood serum in infectious and inflammatory diseases of the anterior segment of the eye. Annals of Ophthalmology = Vestnik oftal’mologii. 2020;2:32–37 (In Russ.). DOI: 10.17116/oftalma202013602132
7. Huang L.Y., Edwards A.O. Acute Bacterial Tenonitis and Conjunctivitis following Intravitreal Injection. Case Reports in Ophthalmology. 2021;12(1):311–314. DOI: 10.1159/000511862
8. Mohamed S., Elmohamady M.N., Abdelrahman S., Amer M.M., Abdelhamid A.G. Antibacterial effects of antibiotics and cell-free preparations of probiotics against Staphylococcus aureus and Staphylococcus epidermidis associated with conjunctivitis. Saudi Pharmaceutical Journal. 2020;28(12):1558–1565. DOI: 10.1016/j.jsps.2020.10.002
9. Kowalski R.P., Nayyar S.V., Romanowski E.G., Shanks R.M.Q., Mammen A., Dhaliwal D.K., Jhanji V. The Prevalence of Bacteria, Fungi, Viruses, and Acanthamoeba From 3,004 Cases of Keratitis, Endophthalmitis, and Conjunctivitis. Eye & Contact Lens-Science and Clinical Practice. 2020;46(5):265–268. DOI: 10.1097/ICL.0000000000000642
10. DeCory H.H. Sanfilippo C.M., Proskin H.M., Blondeau J.M. Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6 %. PloS One. 2020;15(8):e0237603. DOI: 10.1371/journal.pone.0237603
11. Azari A.A., Arabi A. Conjunctivitis: A Systematic Review. Journal of Ophthalmic & Vision Research. 2020;15(3):372–395. DOI: 10.18502/jovr.v15i3.7456
12. Lim L.W., Tan G.S., Yong V., Anderson D.E., Lye D.C., Young B., Agrawal R. Acute Onset of Bilateral Follicular Conjunctivitis in two Patients with Confirmed SARSCoV-2 Infections. Ocular Immunology and Inflammation. 2020;28(8):1280–1284. DOI: 10.1080/09273948.2020.1821901
13. Kaya H., Caliskan A., Okul M., Sari T., Akbudak I.H. Detection of SARS-CoV-2 in the tears and conjunctival secretions of Coronavirus disease 2019 patients. Journal of Infection in Developing Countries. 2020;14(9):977–981. DOI: 10.3855/jidc.13224
14. Nguyen T.T.H., Le T.A., Nguyen V.H., Nguyen T.U., Nguyen P.T., Tran T.T.A., Nguyen Q.H., Hoang A.T., Hoang M.H., Le T.S., Nguyen V.S. Molecular typing of conjunctivitis-causing adenoviruses in Hanoi, Vietnam from 2017 to 2019 and complete genome analysis of the most prevalent type (HAdV-8). Journal of Medical Virology. 2020;92(12):3100–3110. DOI: 10.1002/jmv.25844
15. Efthymios K., Genovefa M., John A., Michael M. Very late onset corneal haze in a photorefractive keratectomy patient associated with presumed viral keratocon‑juctivitis. Indian Journal of Ophthalmology. 2020;68(6):1186. DOI: 10.4103/ijo.IJO_1789_19
16. Bencharki Y., Bouzouba T., Tamym B., Berraho A. Viral conjunctivitis due to molluscum contagiosum in a young immunocompetent woman. Journal Francais d Ophtalmologie. 2020;43(5):455–459. DOI: 10.1016/j.jfo.2019.08.021
17. Arshad S., Petsoglou C., Lee T, Al-Tamimi A., Carnt N.A. 20 years since the Herpetic Eye Disease Study: Lessons, developments and applications to clinical practice. Clinical and Experimental Optometry. 2021;104(3):396–405. DOI: 10.1080/08164622.2021.1877531
18. Ho M.C., Kang E.Y.C., Yeh L.K., Ma DH.K., Lin H.C., Tan H.Y., Chen H.C., Hsiao C.H. Clinico-microbiological profile of Burkholderia cepacia keratitis: a case series. Annals of Clinical Microbiology and Antimicrobials. 2021;20(1):6. DOI: 10.1186/s12941-020-00407-6
19. Rodriguez-Garcia A., Alfaro-Rangel R., Bustamante-Arias A., Hernandez-Camarena J.C. In Vivo Corneal Microstructural Changes in Herpetic Stromal Keratitis: A Spectral Domain Optical Coherence Tomography Analysis. Journal of Ophthalmic & Vision Research. 2020;15(3):279–288. DOI: 10.18502/jovr.v15i3.7446
20. Yeu E., Hauswirth S. A Review of the Differential Diagnosis of Acute Infectious Conjunctivitis: Implications for Treatment and Management. Clinical Ophthalmology. 2020;14:805–813. DOI: 10.2147/OPTH.S236571
21. Arshad J.I., Saud A., White D.E., Afshari N.A., Sayegh R.R. Chronic Conjunctivitis From a Retained Contact Lens. Eye & Contact Lens-Science and Clinical Practice. 2020;46(1):E1–E4. DOI: 10.1097/ICL.0000000000000587
22. Marinos E., Cabrera-Aguas M., Watson S.L. Viral conjunctivitis: a retrospective study in an Australian hospital. Contact Lens & Anterior Eye. 2019;42(6):679–684. DOI: 10.1016/j.clae.2019.07.001
23. Kowalsky D.S., Wolfson A.B. Topical Antibiotics for Clinical and Microbiologic Cure of Bacterial Conjunctivitis. Acad Emerg Med. 2019 Mar;26(3):345–346. doi: 10.1111/acem.13663.
Review
For citations:
Vorobyeva I.V., Frolov M.A., Slonimskiy Yu.B. Analysis of the Assortability of Ophthalmologists Using a Therapy as Part of Routine Medical Care for Patients with Inflammatory Eye Diseases. Ophthalmology in Russia. 2021;18(3):566-577. (In Russ.) https://doi.org/10.18008/1816-5095-2021-3-566-577
Views:
558
Email this article 